Simpa Salami

Has grant

University of Michigan

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Radiogenomic Characterization of Prostate Cancer: Distinguishing Aggressive from Indolent Disease

Open Date: 2020-08-01

Close Date: 2022-09-29

Articles (29)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (4)

Cathryn Lapedis

University of Michigan

UNITED STATES

View details

Todd Morgan

University of Michigan

UNITED STATES

View details

Daniel Barocas

Professor and Executive Vice Chair

Vanderbilt University Medical Center

UNITED STATES

View details

Andi Cani

University of Michigan

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Simpa Salami

Research Interests

Explore related searches

Contact this professor

Recent Grants

Articles (29)

Editorial Comment

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening: Erratum.

Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell Carcinoma

Darolutamide plus androgen-deprivation therapy: propensity score matching of ARASEC and historic clinical trial patients

Digital Rectal Exam no More: Validated Accuracy of MYPROSTATESCORE 2.0 (MPS2) Using First-Catch, Non-DRE Urine

IP16-30 DO TISSUE-BASED BIOMARKERS IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA PERFORM BETTER WHEN DERIVED FROM A METASTATIC SITE COMPARED TO THE PRIMARY?

MP04-20 SEXUAL AND URINARY FUNCTIONAL OUTCOMES FOLLOWING FOCAL THERAPY FOR PROSTATE CANCER

MP28-03 VALIDATION OF A 15-GENE PROGNOSTIC SIGNATURE IN METASTATIC CLEAR CELL RENAL CELL CARCINOMA

PD10-05 NARROW RANGE MOLECULAR INFLUENCE OF PROSTATE TUMORS ON SURROUNDING TISSUE REVEALED BY SPATIAL GENOMICS

PD10-11 DIGITAL SPATIAL PROFILING REVEALS TRANSCRIPTOMIC HETEROGENEITY OF PROSTATE CANCER IN PATIENTS WITH GERMLINE MUTATIONS

A longitudinal mixed-methods study of pathology explanation clinics in patients with newly diagnosed localized prostate cancer

Integrative multi-region molecular profiling of primary prostate cancer in men with synchronous lymph node metastasis

Differences in mutations across tumour sizes in clear‐cell renal cell carcinoma

A Systematic Review of Family History, Race/Ethnicity, and Genetic Risk on Prostate Cancer Detection and Outcomes: Considerations in PSA-based Screening

Discovery and Validation of a 15-Gene Prognostic Signature for Clear Cell Renal Cell Carcinoma

PD16-04 SPATIAL ANALYSIS OF PRIMARY AND METASTATIC LESIONS IN SARCOMATOID RENAL CELL CARCINOMA REVEALS INSIGHT TO TUMOR BIOLOGY AND IMMUNE MICROENVIRONMENT

PD16-05 EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND PD-1/PD-L1 SIGNALING PROVIDE RECIPROCAL FEEDBACK IN RENAL CELL CARCINOMA PROGRESSION WITH IMPLICATIONS FOR IMMUNOTHERAPY RESPONSE

PD45-04 DOES DRE ADD VALUE TO THE AUA PROSTATE CANCER RISK STRATIFICATION?

EPITHELIAL TO MESENCHYMAL TRANSITION (EMT) AND PD-1/PD-L1 SIGNALING PROVIDE RECIPROCAL FEEDBACK IN RENAL CELL CARCINOMA PROGRESSION WITH IMPLICATIONS FOR IMMUNOTHERAPY RESPONSE

Association of transitional gradient from clear cell to sarcomatoid renal cell carcinoma with macrophage/tumor cell crosstalk.

Comparing Patient-reported Functional Outcomes After Radical Prostatectomy in Historical and Contemporary Practice.

Current Landscape of Genomic Biomarkers in Clear Cell Renal Cell Carcinoma

Michigan Urology Academy-Our Role in Diversifying the Urology Workforce.

Abstract PR014: Macrophage induced epithelial to mesenchymal transition in sarcomatoid renal cell carcinoma

Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening

Early Detection of Prostate Cancer: AUA/SUO Guideline Part II: Considerations for a Prostate Biopsy

Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer

Open-label study of darolutamide plus androgen-deprivation therapy (ADT) vs ADT in metastatic hormone-sensitive prostate cancer using an external control arm (ARASEC).

Abstract 4700: Spatial analysis of the immune microenvironment and tumor cell transition in sarcomatoid renal cell carcinoma

Collaborators (4)

Cathryn Lapedis

Todd Morgan

Daniel Barocas

Andi Cani

Make your next move.